Research Field: Virology, vaccine
Chikungunya virus (CHIKV) is a mosquito-borne virus that has emerged as a major global human pathogen, causing explosive outbreaks of debilitating and sometimes fatal disease. Worldwide, CHIKV affects 3.4% of the population each year with no vaccine currently available.
Dr Taylor’s research has shown that disrupting the movement of viral proteins in the cell can weaken or attenuate CHIKV. Attenuated CHIKV produces no disease signs during infection and offers protection from reinfection. This research has produced a live-attenuated CHIKV vaccine candidate that offers a strong protective immune response against CHIKV disease.
Dr Taylor has provided information to media on the safety and efficacy of SARS-CoV-2 Vacccines and has written multiple, widely-read articles for the conversation.
He has presented his research at community events that “take science to the street”, including presenting at BrisScience, the QLD State Library and QLD Fresh Science.
Adam was awarded his PhD in Molecular and Cellular Biology at the University of Leeds in 2011. He is currently an Early Career Research Leader at the Menzies Health Institute Queensland, Griffith University.